Stocks and Investing
Stocks and Investing
Mon, August 5, 2024
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
Srikripa Devarakonda Reiterated (BIIB) at Strong Buy with Decreased Target to $302 on, Aug 5th, 2024
Srikripa Devarakonda of Truist Securities, Reiterated "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $340 to $302 on, Aug 5th, 2024.
Srikripa has made no other calls on BIIB in the last 4 months.
There are 14 other peers that have a rating on BIIB. Out of the 14 peers that are also analyzing BIIB, 6 agree with Srikripa's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $190 on, Friday, August 2nd, 2024
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $210 on, Friday, August 2nd, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Decreased Target to $225 on, Friday, August 2nd, 2024
- Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
- Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
- Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024
These are the ratings of the 8 analyists that currently disagree with Srikripa
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $292 on, Friday, August 2nd, 2024
- George Farmer of "Scotiabank" Maintained at Buy with Decreased Target to $244 on, Friday, August 2nd, 2024
- Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
- Morten Herholdt of "HSBC" Maintained at Strong Buy with Increased Target to $342 on, Friday, May 3rd, 2024
- Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $270 on, Monday, April 29th, 2024
Contributing Sources